Tracking a gut treatment to stop a dangerous infection from coming back

NCT ID NCT05835219

Completed Prevention Sponsor: Ferring Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study observed 145 adult patients who received REBYOTA, a treatment designed to prevent repeat C. difficile infections. Researchers tracked patients for 6 months after treatment to see if the infection returned and to monitor their health. The main goal was to see how many patients remained infection-free after receiving REBYOTA in a real-world medical setting.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Ferrin Investigational Site

Atlanta, Georgia, 30322, United States
Ferring Investigational Site

Chandler, Arizona, 85224, United States
Ferring Investigational Site

Chula Vista, California, 91910, United States
Ferring Investigational Site

Murrieta, California, 92563, United States
Ferring Investigational Site

Oceanside, California, 92054, United States
Ferring Investigational Site

Sacramento, California, 95816, United States
Ferring Investigational Site

Hamden, Connecticut, 06518, United States
Ferring Investigational Site

Gainesville, Florida, 32610, United States
Ferring Investigational Site

Orlando, Florida, 32806, United States
Ferring Investigational Site

Port Orange, Florida, 32127, United States
Ferring Investigational Site

Tampa, Florida, 33614, United States
Ferring Investigational Site

Zephyrhills, Florida, 33542, United States
Ferring Investigational Site

La Grange, Georgia, 30240, United States
Ferring Investigational Site

Savannah, Georgia, 31405, United States
Ferring Investigational Site

Burr Ridge, Illinois, 60527, United States
Ferring Investigational Site

Maywood, Illinois, 60153, United States
Ferring Investigational Site

Iowa City, Iowa, 52242, United States
Ferring Investigational Site

Wichita, Kansas, 67211, United States
Ferring Investigational Site

Jefferson, Louisiana, 70121, United States
Ferring Investigational Site

Boston, Massachusetts, 02115, United States
Ferring Investigational Site

Worcester, Massachusetts, 01608, United States
Ferring Investigational Site

Detroit, Michigan, 48201, United States
Ferring Investigational Site

Detroit, Michigan, 48202, United States
Ferring Investigational Site

Farmington Hills, Michigan, 48336, United States
Ferring Investigational Site

Omaha, Nebraska, 68198, United States
Ferring Investigational Site

Teaneck, New Jersey, 07666, United States
Ferring Investigational Site

New York, New York, 10016, United States
Ferring Investigational Site

New York, New York, 10021, United States
Ferring Investigational Site

New York, New York, 10279, United States
Ferring Investigational Site

Rochester, New York, 14618, United States
Ferring Investigational Site

Stony Brook, New York, 11794, United States
Ferring Investigational Site

Fargo, North Dakota, 58122, United States
Ferring Investigational Site

Cincinnati, Ohio, 45267, United States
Ferring Investigational Site

Middleburg Heights, Ohio, 44130, United States
Ferring Investigational Site

DuBois, Pennsylvania, 15801, United States
Ferring Investigational Site

Pittsburgh, Pennsylvania, 15237, United States
Ferring Investigational Site

Charleston, South Carolina, 29425, United States
Ferring Investigational Site

Knoxville, Tennessee, 37909, United States
Ferring Investigational Site

Dallas, Texas, 75246, United States
Ferring Investigational Site

Houston, Texas, 77030, United States
Ferring Investigational Site

West Jordan, Utah, 84088, United States
Ferring Investigational Site

Charlottesville, Virginia, 22903, United States

Conditions

Explore the condition pages connected to this study.

RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION